Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
The "vicious cycle" established between tumor growth and osteolysis aggravates the process of breast cancer bone metastasis, leading to life-threatening skeletal-related events that severely reduce survival and quality of life. To effectively interrupt the "vicious cycle", innova...
Saved in:
Main Authors: | Yanjuan Huang (Author), Zhanghong Xiao (Author), Zilin Guan (Author), Zishan Zeng (Author), Yifeng Shen (Author), Xiaoyu Xu (Author), Chunshun Zhao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment
by: Xiangyu Zhang, et al.
Published: (2022) -
Zoledronic acid inhibits the bone metastasis of breast cancer by repressing exosome-loaded DKK1
by: Bin Bin Song, et al.
Published: (2022) -
Zoledronic acid in the management of metastatic bone disease
by: Thomas J Polascik, et al.
Published: (2008) -
Increased bone mass but delayed mineralization: in vivo and in vitro study for zoledronate in bone regeneration
by: Rongchang Wang, et al.
Published: (2024) -
Effect of local injection of Zolena, zoledronic acid made in Iran, on orthodontic tooth movement and root and bone resorption in rats
by: Massoud Seifi, et al.
Published: (2017)